MELISSA RIKAL: Open Payments
NPI 1417373267 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$64,644 in 165 payments from 24 companies in 2025. Trend: 2023 $233 · 2024 $43,595 · 2025 $64,644
Speaker / faculty: $47,400Travel & lodging: $12,983Food & beverage: $3,136Consulting: $1,125
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 96 | $49,197 |
| AstraZeneca Pharmaceuticals LP | 23 | $14,464 |
| Regeneron Healthcare Solutions, Inc. | 11 | $252 |
| Janssen Biotech, Inc. | 5 | $102 |
| Caris MPI, Inc. | 5 | $94 |
| Novartis Pharmaceuticals Corporation | 3 | $87 |
| AVYXA PHARMA, LLC | 2 | $46 |
| E.R. Squibb & Sons, L.L.C. | 2 | $37 |
| PFIZER INC. | 2 | $37 |
| Merck Sharp & Dohme LLC | 2 | $32 |
Products named: Enhertu, DATROWAY, LIBTAYO, MI CANCER SEEK, KISQALI, RYBREVANT, ERLEADA, OPDIVO.
Industry payments across TN — which companies pay providers there.
